Richard has more than 30 years’ experience in the in vitro diagnostics (IVD) industry. Currently, Dr. Creager is a partner in IOI Partners, a management consulting firm for IVD and biotechnology companies. Previously, Richard was SVP for Molecular Diagnostics and Chief Science Officer for Beckman Coulter from 2011 – 2016. He also served as Group Vice President for Beckman Coulter’s Immunoassay Business and led the growth of that business from ~ $40m to more than $700m (1997 – 2011). During his tenure, he was instrumental in identifying acquiring several key technologies and companies. He also successfully launched several innovative biomarkers that helped drive the growth of the company.
Dr. Creager also held senior executive positions with Kallestad Diagnostics Sanofi Diagnostics Pasteur, the latter at which he led the development of that company’s first automated immunoassay analyzer. Richard was the chairman of the board of directors for Medical Alley, a 501(c)3 non-profit trade association that enables health technology and care organizations to innovate, succeed, and influence the evolution of healthcare in Minnesota and the surrounding region. Formerly he served as an editorial board member for In Vitro Diagnostics Technology/Dx.
He currently serves on the board of two non-profits:  [email protected], which serves to strengthen STEM education in Orange County middle schools and  1for2 education foundation, whose mission is to build a community of scholars, dedicated to being life-long learners and are committed to “pay-it-forward.” He also serves on the board of OnRamp Bioinformatics. Richard has a B.S. from Muhlenberg College, a M.S. from Duquesne University, and a PhD from the University of Pittsburgh School of Medicine. He also attended The Wharton School of Business for their Advanced Management Program.